Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the escalating incidence of unintended pregnancies, increased awareness and education ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and other autoimmune disorders, ... Read More
-
Global Clostridium Vaccine (Animal Health) Market Research Report 2024(Status and Outlook)
... pulpy kidney (enterotoxaemia), and blackleg. The Global Clostridium Vaccine (Animal Health) Market Size was estimated at USD 443.05 million in 2023 and is projected to reach USD 522.90 million by 2029, exhibiting a CAGR of ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Asia Pacific, Middle East & Africa) Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene ... Read More
-
Chicory Market By Product Type (Extract, Roasted, Instant Powder, Flour) , By Form (Powder, Cube, Liquid) By Application (Food and Beverage Industry, Dietary Supplement, Feed and Pet Food, Cosmetics and Personal Care, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2034
... Opportunity Analysis and Industry Forecast, 2024-2034 The chicory market was valued at $725.3 million in 2023, and is projected to reach $985.5 million by 2034, growing at a CAGR of 2.9% from 2024 to 2034. ... Read More
-
Heart Healthy Ingredients
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Omega-3, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$12.4 Billion by the ... Read More
-
Ophthalmic Perimeters - Market Insights, Competitive Landscape, and Market Forecast - 2030
... And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of eye conditions such as such as glaucoma, cataract, ... Read More
-
Ophthalmic Knives - Market Insights, Competitive Landscape, and Market Forecast - 2030
... And Others), Application (Cataract, Trachoma, Glaucoma, And Others), End-User (Hospitals, Ophthalmic Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till ... Read More
-
UAE Weight Loss Market Report by Diet (Supplements, Meals, Beverages), Equipment (Fitness Equipment, Surgical Equipment), Service (Fitness Centers and Health Clubs, Consulting Service, Surgical Clinics, Online Weight Loss Programs, and Others), Gender (Men, Women), Age Group (Consumers Between 31 to 60 Years of Age, Consumers Between 15 to 30 Years, Consumers with Age More Than 60 Years, Consumer with Age Below 15 Years) 2024-2032
... Group (Consumers Between 31 to 60 Years of Age, Consumers Between 15 to 30 Years, Consumers with Age More Than 60 Years, Consumer with Age Below 15 Years) 2024-2032 The UAE weight loss market size ... Read More
-
Global Home Infusion Therapy Market Forecast Report By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infective, Hydration Therapy, Chemotherapy, Enternal Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others), Countries and Company Analysis 2024-2032
... Home Infusion Therapy Market Analysis The home infusion therapy market is anticipated to reach US$ 72.84 billion by 2032 from US$ 42.70 billion in 2023, growing at a CAGR of 6.12% between 2024 and 2032. ... Read More
-
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Pain Management Drugs Market The pain management drugs market was valued at $72.6 billion in 2023 ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Soldier Systems
... at a CAGR of 5.0% over the analysis period 2023-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
mRNA Platform
... at a CAGR of -3.1% over the analysis period 2023-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.1% CAGR and reach US$96.5 Billion by the end of ... Read More
-
Color Cosmetics
... at a CAGR of 4.6% over the analysis period 2023-2030. Color Cosmetics for Prestige Product Market, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$73.0 Billion ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Anti-Counterfeit Packaging
... at a CAGR of 9.3% over the analysis period 2023-2030. Mass Encoding Technology, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$109.6 Billion by the end ... Read More
-
Enteral Feeding Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Enteral Feeding Tubes, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.5 Billion ... Read More
-
Pulmonary Arterial Hypertension (PAH)
... reach US$9.8 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Prostacyclin & Prostacyclin Analogs Drug Class, one of the segments analyzed in the report, is expected to record a ... Read More
-
Blood Pressure Monitoring and Measurement Instruments
... the year 2023, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Sphygmomanometers, one of the segments analyzed in the report, is expected to record ... Read More
-
Anti-Hypertensive Drugs
... at a CAGR of 2.8% over the analysis period 2023-2030. Calcium Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$7.2 Billion by the end ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... the year 2023, is expected to reach US$57.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to ... Read More
-
Chiropractic Care
... at a CAGR of 3.6% over the analysis period 2023-2030. Relief Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$25.6 Billion by the end of ... Read More
-
Biotechnology Product Manufacturing
... (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ... Read More
Research Assistance
